44 component-labeling-cuda Fellowship positions at University of Nottingham in United Kingdom
Sort by
Refine Your Search
-
their application clearly which they are familiar with and their degree of expertise). Experience of geo-coded data analyses and Propensity Score Matching would also be relevant. Expert interviews will also form part
-
groundwork for subsequent human clinical trials. You will work as part of an interdisciplinary team involving pancreatic cancer surgeons, pathologists, and engineers. There will be significant potential
-
development proposals and funding bids. To take the lead on, plan, develop and conduct individual and/or collaborative research objectives, projects and proposals either as an individual or as part of a broader
-
to an exciting new effort to accelerate and miniaturise micro-elasticity imaging systems for in-vivo and clinical applications. You will be part of a dynamic, interdisciplinary team aiming
-
are interested in part-time work, we encourage you to apply. Please specify your preferred hours in your application. We may also consider job share arrangements. Please contact Beatrix Gateb
-
. About the team You will join the lab of Dr Sophie Kellaway as part of the Blood Cancer and Stem Cell group (https://bcasc.co.uk/). You will work closely with a research technician. You will have the
-
the role profile. To apply for this vacancy please click ‘Apply Now’ to complete your details. This is a full-time (36.25 hours per week) but open to part-time, fixed-term appointment for 12 months
-
Applications are invited for the post of Research Fellow in the School of Chemistry. The research project is part of an exciting multi-disciplinary collaboration involving academia and industry
-
flow in hybrid systems: improving the simulation of engineering structures”. As part of the project - jointly undertaken by the University of Nottingham and the University of Salford -, we offer a
-
, conducting, and writing up research as part of an MRC project led by Dr Tanya Monaghan on developing and evaluating microRNA-based nanoscale delivery systems for inflammatory bowel disorders. The work focuses